Medicalgorithmics, a member of the sWIG80 medtech index, recaps 2023 - a year marked by the implementation of a new growth strategy and a successful transition of the business model.
Implementing its ongoing strategy, Medicalgorithmics, a medtech company listed on the sWIG80 index, has successfully added nine new clients, including five Independent Diagnostic.
Medicalgorithmics has initiated its involvement in providing cardiac safety services for a pioneering clinical trial of a new medication. The trial, now in the drug dosing phase,.
At the Extraordinary General Meeting on December 19th, this medtech company, part of the sWIG80 index, set up an incentive program for executives and key staff. The success of this.
Medicalgorithmics, a MedTech company listed in the sWIG80 index, continues to successfully transform its business model in line with the objectives defined in its new development.